BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

815 related articles for article (PubMed ID: 19398348)

  • 1. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
    Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
    Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current practices and future directions of therapeutic strategy in glioblastoma: survival benefit and indication of BNCT.
    Matsumura A; Yamamoto T; Tsurubuchi T; Matsuda M; Shirakawa M; Nakai K; Endo K; Tokuue K; Tsuboi K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S12-4. PubMed ID: 19375923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
    Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
    Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice.
    Zavjalov E; Zaboronok A; Kanygin V; Kasatova A; Kichigin A; Mukhamadiyarov R; Razumov I; Sycheva T; Mathis BJ; Maezono SEB; Matsumura A; Taskaev S
    Int J Radiat Biol; 2020 Jul; 96(7):868-878. PubMed ID: 32339057
    [No Abstract]   [Full Text] [Related]  

  • 7. Boron neutron capture therapy for newly diagnosed glioblastoma: a pilot study in Tsukuba.
    Yamamoto T; Nakai K; Tsurubuchi T; Matsuda M; Shirakawa M; Zaboronok A; Endo K; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S25-6. PubMed ID: 19375927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boron neutron capture therapy using mixed epithermal and thermal neutron beams in patients with malignant glioma-correlation between radiation dose and radiation injury and clinical outcome.
    Kageji T; Nagahiro S; Matsuzaki K; Mizobuchi Y; Toi H; Nakagawa Y; Kumada H
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1446-55. PubMed ID: 16750328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival benefit of boron neutron capture therapy for recurrent malignant gliomas.
    Miyatake S; Kawabata S; Yokoyama K; Kuroiwa T; Michiue H; Sakurai Y; Kumada H; Suzuki M; Maruhashi A; Kirihata M; Onoc K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S22-4. PubMed ID: 19394240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
    Monti Hughes A; Heber EM; Pozzi E; Nigg DW; Calzetta O; Blaumann H; Longhino J; Nievas SI; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S313-7. PubMed ID: 19376711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boron neutron capture therapy at the crossroads: challenges and opportunities.
    Barth RF
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S3-6. PubMed ID: 19467879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
    Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boron neutron capture therapy for murine malignant gliomas.
    Saris SC; Solares GR; Wazer DE; Cano G; Kerley SE; Joyce MA; Adelman LS; Harling OK; Madoc-Jones H; Zamenhof RG
    Cancer Res; 1992 Sep; 52(17):4672-7. PubMed ID: 1511433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase I study.
    Kankaanranta L; Seppälä T; Koivunoro H; Välimäki P; Beule A; Collan J; Kortesniemi M; Uusi-Simola J; Kotiluoto P; Auterinen I; Serèn T; Paetau A; Saarilahti K; Savolainen S; Joensuu H
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):369-76. PubMed ID: 21236605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between radiation dose and histopathological findings in patients with gliblastoma treated with boron neutron capture therapy (BNCT).
    Kageji T; Mizobuchi Y; Nagahiro S; Nakagawa Y; Kumada H
    Appl Radiat Isot; 2014 Jun; 88():20-2. PubMed ID: 24480727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neutron capturing irradiation: principle, current results and perspectives].
    Pignol JP; Chauvel P
    Bull Cancer Radiother; 1995; 82(3):283-97. PubMed ID: 8554878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
    Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boron neutron capture therapy for glioblastoma.
    Yamamoto T; Nakai K; Matsumura A
    Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.